Showing results (11-20 of 491) with videos related to
Sort By:
Pageof 50
Current Opinion in Hematology|November 5, 1999
Radionuclides as conditioning before stem cell transplantationJ G Jurcic, D A ScheinbergCurrent Opinion in Immunology|October 1, 1994
Recent developments in the radioimmunotherapy of cancerJ G Jurcic, D A ScheinbergLeukemia & Lymphoma|January 1, 1993
Anti-CD33 monoclonal antibody M195 for the therapy of myeloid leukemiaP C Caron, D A ScheinbergCancer Investigation|January 1, 1997
The biological therapy of acute and chronic leukemiaP C Caron, D A ScheinbergOncology (Williston Park, N.Y.)|May 1, 1987
Current status of antitumor therapy with monoclonal antibodiesD A Scheinberg, A N HoughtonBiochemical and Biophysical Research Communications|March 17, 1995
Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase NY Xu, D Wellner, D A ScheinbergThe New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.Experimental Hematology|June 1, 1997
Cryptic and regulatory epitopes in CD13/aminopeptidase NY Xu, D Wellner, D A ScheinbergBone Marrow Transplantation|October 26, 2005
Radioimmunoconjugates in acute leukemia treatment: the future is radiantJ Kotzerke, D Bunjes, D A ScheinbergBlood Reviews|September 30, 2000
CML vaccines as a paradigm of the specific immunotherapy of cancerJ Pinilla-Ibarz, K Cathcart, D A ScheinbergPageof 50